Description

Tofacitinib and Malignancy Risk: Dr. Seoyoung Kim
Potpourri of Biosimilar Trials: Dr. Jonathan Kay
Closing a Chapter: Interview with the 84th ACR President 2020-2021, Kathryn Dao